Screener
Madrigal Pharmaceuticals, Inc. MDGL Total Non-Current Liabilities
Total Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesNoncurrent.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Long term liabilities: | ||
| Loan payable, net of discount | 340,794 | 339,881 |
| Operating lease liabilities, net of current portion | 5,923 | 6,731 |
| Total long term liabilities | 346,717 | 346,612 |
| Total liabilities | 720,921 | 656,900 |
| Stockholders’ equity: | ||
| Preferred stock, par value $0.0001 per share authorized: 5,000,000 shares at June 30, 2026 and December 31, 2025; 2,369,797 shares issued and outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, par value $0.0001 per share authorized: 200,000,000 shares at June 30, 2026 and December 31, 2025; 23,093,974 and 22,842,073 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 2 | 2 |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s total non-current liabilities?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported total non-current liabilities of $346.72M in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s total non-current liabilities changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s total non-current liabilities increased by 182.1% year-over-year, from $122.9M to $346.72M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s total non-current liabilities?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s total non-current liabilities has grown at a 274.9% compound annual growth rate (CAGR), from $468K to $346.61M.
- What does total non-current liabilities mean?
- The sum of all long-term obligations due beyond one year — long-term debt, lease liabilities, pension obligations, and deferred items.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s total non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude